SUGAR LAND--January 21, 2009--Researched by Industrial Info Resources (Sugar Land, Texas)--Genentech Incorporated (NYSE:DNA) (San Francisco, California) recently announced a fourth-quarter 2008 net income of $931 million, up 47% compared with $632 million in the same period of 2007. Sales for the quarter rose 13% to $2.5 billion, compared with $2.2 billion in the fourth quarter of 2007. Industrial Info is tracking two active Genentech projects worth $300 million as part of our Pharmaceutical Tracker - Online Database. The larger of the two projects is a grassroot biotherapeutic fill and finish plant in Hillsboro, Oregon. Hillsboro is one of three locations that Genentech has targeted to ramp up manufacturing, Chairman and CEO Arthur Levinson said.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
